Does Boron Help With Skin Cancer Response?
BNCT showed a 70% response rate in patients with scalp angiosarcoma and malignant melanoma.
Weak EvidenceEvidence Summary
BNCT showed a 70% response rate in patients with scalp angiosarcoma and malignant melanoma.
Effective Dose
Medical procedure — not a supplement dose